冷泉港亞洲2013會議：腫瘤免疫及免疫療法
Tumor Immunology and Immunotherapy
腫瘤免疫及免疫療法
2013年10月28 – 11月1日 | 蘇州. 獨(dú)墅湖會議酒店
http://www.csh-asia.org/13Immune.html
科學(xué)組委會成員:
Xuetao Cao, Chinese Academy of Medical Sciences, China
Xin-Yuan Fu, National University of Singapore, Singapore
Olivera Finn, University of Pittsburgh School of Medicine, USA
Cornelius Melief, Leiden University Medical Center, The Netherlands
會議主題：
1. Cancer vaccines
2. Antibody therapy
3. Adoptive T cell therapy
4. Combination of immunotherapy with other therapies
5. Cancer, inflammation and immunosuppression
6. Immune escape of cancer
7. Aging, immunity and cancer
8. Oncogenic viruses, immunity and immunotherapy
主題演講嘉賓:
David Baltimore, California Institute of Technology, USA
Engineering Immunologic Protection and Therapy
Xiaodong Wang, National Institute of Biological Sciences, China
TNFalpha and TLR3/4 induced necrosis pathway
特邀演講嘉賓:
Jean Pierre Abastado, Singapore Immunology Network, Singapore
Cancer cells hijack immune cells for dissemination and metastasis.
Jannie Borst, The Netherlands Cancer Institute, The Netherlands
Mechanistic insights in T-cell costimulation by the CD27/CD70 pathway encourage application in cancer immunotherapy
Jay Berzofsky, National Cancer Institute, USA
Cancer Vaccines: Basic strategies and clinical translation
Vincenzo Bronte, University of Verona, Italy
Molecular and metabolic control of adaptive immunity by tumor-induced myelopoiesis
Xuetao Cao, Chinese Academy of Medical Sciences, China
New cell subsets in tumor immune escape and metastasis
Yuan Chang, University of Pittsburgh Cancer Institute, USA
Merkel cell polyomavirus: a model in tumorigenesis and immunity
Lieping Chen, Yale School of Medicine, USA
Inhibiting co-inhibitors for immunotherapy of cancer
Olivera Finn, University of Pittsburgh School of Medicine, USA
Disease associated antigens as targets for cancer immunosurvellance and candidates for prophylactic cancer vaccines
Xin-Yuan Fu, National University of Singapore, Singapore
An Inducible Cancer Metastatic Niche Mediated by Endothelial STAT3
Yang-Xin Fu, The University of Chicago, USA
Changing tumor microenvironment by local ablative radiation and modified antibody for better immunotherapy
Yukai He, Georgia Regents University Cancer Center, USA
Engineering epitope-optimized AFP-based gene vaccines to prevent autochthonous hepatocellular carcinoma
Erica Jensen Jarolim, Medical University Vienna, Austria
Comparative oncology: Development of xenogenic vaccines and recombinant antibodies for dog mammary cancer patients.
Dieter Kabelitz, University of Kiel, Germany
Towards improving immunotherapeutic strategies with human gamma/delta T-cells
Yutaka Kawakami, Keio University School of Medicine, Japan
Different tumor immunoenvironments among patients and their modification by molecular targeted therapy
Binfeng Lu, University of Pittsburgh School of Medicine, USA
Danger signal IL-33 and antitumor Immunity
Ignacio Melero, University of Navarra, Spain
unfolding CD137-based cancer immunotherapy
Cornelius Melief, Leiden University Medical Center, The Netherlands
TLR-ligand peptide conjugates for superior therapeutic vaccination against immunogenic cancers
Ira Mellman, Genentech, USA
Oncology meets immunology: targeting PD-L1 in combination
Andrew Mellor, Georgia Regents University, USA
A Tale with a STING: Pivotal pathways that control immune responses to DNA
Graham Pawelec, University of Tuebingen Center for Medical Research, Germany
Immunosenescence and cancer
Zhihai Qin ,Chinese Academy of Sciences, China
S100A4(FSP-1)promotes liver fibrosis and hepatocellular carcinoma
Michel Sadelain, Memorial Sloan-Kettering Cancer Center, USA
Targeting tumors with genetically enhanced T lymphocytes
Mark Smyth, Queensland Institute of Medical Research in Brisbane, Australia
Receptor ligand interactions that regulate tumor growth and metastases
Cassian Yee, UT MD Anderson Cancer Center, USA
Adoptive T Cell Therapy of Cancer: Age of Renaissance
Hua Yu, City of Hope Duarte, USA
Pathways to Targeting STAT3: Transition into the Clinic
Rong-Fu Wang, The Methodist Hospital Research Institute Houston, USA
Innate signaling and antigen-specific cancer immunotherapy
Limin Zheng, Sun Yat-sen University, China
Macrophage Plasticity in Distinct Microenvironments of Human Tumors
Weiping Zou, University of Michigan Medical School, USA
Immune elements shape cancer stemness
|
|
聯(lián)系方式： Cold Spring Harbor Asia No.299 Qiyue Road, SIP/ Suzhou, Jiangsu Province, China Tel: +86-512-62729029 Fax: +86-512-62729028 Email: mikeji@cshl.edu Website: www.csh-asia.org |
相關(guān)鏈接： 2013年冷泉港亞洲（CSH Asia）會議搶先預(yù)覽！
- CGT Asia 第十屆亞洲細(xì)胞與基因治療創(chuàng)新峰會通知
- 禮智生物將亮相大灣區(qū)腦病中醫(yī)藥科創(chuàng)與產(chǎn)學(xué)研大會
- NEW-MED 2026生物材料研發(fā)及應(yīng)用峰會通知
- 隱智科儀攜智能儀器解決方案亮相華人生物分析論壇
- 2026生物農(nóng)藥研發(fā)創(chuàng)制與農(nóng)藥制劑加工研討會通知
- 2026第八屆國際功能醫(yī)學(xué)創(chuàng)新大會通知
- CGLTS2025北京細(xì)胞與基因免疫治療亦莊峰會通知
- 第11屆全國植物生物學(xué)與植物逆境生物學(xué)研討會通知
- 2026作物高產(chǎn)高效栽培與生態(tài)耕作學(xué)術(shù)研討會通知
- 2026廣西臨床檢驗儀器、試劑與輸血用品展覽會通知
- 北京基爾比攜類器官科研儀器參加BSCB2025學(xué)術(shù)年會
- 華威中儀邀您參加2025全國海洋微生物學(xué)學(xué)術(shù)研討會
- CBIC 2026細(xì)胞生物產(chǎn)業(yè)大會邀請函
- 霍爾斯攜經(jīng)典發(fā)酵罐及切向流超濾系統(tǒng)亮相BioONE2025
- 慧榮和亮相中國毒理學(xué)會農(nóng)藥毒理學(xué)專委會成立大會
- 尚恩生物推出暖冬實驗禮包促銷活動
- 尚恩生物雙11科研狂歡，惠禮雙擎！限時啟動！
- 尚恩生物流式抗體及完整解決方案全面上線
- 開學(xué)季鉅惠來襲，尚恩生物推出超值細(xì)胞啟動套裝
- 尚恩生物誠邀您參觀2025CILSE生命科學(xué)大會
- 尚恩生物明星細(xì)胞株MH7A首次5折優(yōu)惠限時速購！
- 美森與您相約CMC-CHINA第七屆中國制藥工業(yè)博覽會
- 美森攜CTCC細(xì)胞庫與干細(xì)胞技術(shù)亮相東南大學(xué)高研院
- 尚恩生物暑期特惠：胞折扣30%，三大套餐1180元起！
- 尚恩生物推出原代細(xì)胞熱銷款限時特惠活動！
- 賽業(yè)生物直播預(yù)告：細(xì)胞培養(yǎng)的難點與解決方案
- 尚恩生物五一福利局，配套試劑一步到位！
- 細(xì)胞檢測試劑盒免費(fèi)送，反饋即享100%京東卡好禮！
- 2025動物生物育種與繁殖技術(shù)學(xué)術(shù)交流研討會通知
- 開年上新：尚恩生物細(xì)胞轉(zhuǎn)染服務(wù)正式上線啦!
Copyright(C) 1998-2025 生物器材網(wǎng) 電話：021-64166852;13621656896 E-mail：info@bio-equip.com